University Hospitals Bristol NHS Trust, Bristol, United Kingdom.
Blood. 2010 Jul 22;116(3):366-74. doi: 10.1182/blood-2010-01-264077. Epub 2010 Apr 19.
We examined the efficacy of reduced-intensity conditioning (RIC) and compared outcomes of 93 patients older than 16 years after RIC with 1428 patients receiving full-intensity conditioning for allografts using sibling and unrelated donors for Philadelphia-negative acute lymphoblastic leukemia (ALL) in first or second complete remission. RIC conditioning included busulfan 9 mg/kg or less (27), melphalan 150 mg/m(2) or less (23), low-dose total body irradiation (TBI; 36), and others (7). The RIC group was older (median 45 vs 28 years, P < .001) and more received peripheral blood grafts (73% vs 43%, P < .001) but had similar other prognostic factors. The RIC versus full-intensity conditioning groups had slightly, but not significantly, less acute grade II-IV graft-versus-host disease (39% vs 46%) and chronic graft-versus-host disease (34% vs 42%), yet similar transplantation-related mortality. RIC led to slightly more relapse (35% vs 26%, P = .08) yet similar age-adjusted survival (38% vs 43%, P = .39). Multivariate analysis showed that conditioning intensity did not affect transplantation-related mortality (P = .92) or relapse risk (P = .14). Multivariate analysis demonstrated significantly improved overall survival with: Karnofsky performance status more than 80, first complete remission, lower white blood count, well-matched unrelated or sibling donors, transplantation since 2001, age younger than 30 years, and conditioning with TBI, but no independent impact of conditioning intensity. RIC merits further investigation in prospective trials of adult ALL.
我们研究了减低强度预处理(RIC)的疗效,并比较了 93 例年龄大于 16 岁的患者和 1428 例接受同胞和非血缘供者全强度预处理的患者的结局,这些患者为费城染色体阴性的急性淋巴细胞白血病(ALL),处于首次或第二次完全缓解期。RIC 预处理方案包括马利兰 150mg/m2 或以下(23),白消安 9mg/kg 或以下(27),低剂量全身照射(TBI;36),和其他(7)。RIC 组年龄较大(中位数 45 岁比 28 岁,P<0.001),更多患者接受外周血移植(73%比 43%,P<0.001),但其他预后因素相似。RIC 组与全强度预处理组的急性Ⅱ-Ⅳ度移植物抗宿主病(GVHD)发生率(39%比 46%)和慢性 GVHD 发生率(34%比 42%)虽略有降低,但无显著差异,然而移植相关死亡率相似。RIC 组复发率略高(35%比 26%,P=0.08),但年龄调整后的生存率相似(38%比 43%,P=0.39)。多变量分析显示预处理强度不影响移植相关死亡率(P=0.92)或复发风险(P=0.14)。多变量分析显示,Karnofsky 体能状态评分>80,首次完全缓解,白细胞计数较低,供者匹配良好(无关或同胞),2001 年后接受移植,年龄小于 30 岁,以及 TBI 预处理与总生存时间明显改善相关,但预处理强度无独立影响。RIC 值得在成人 ALL 的前瞻性试验中进一步研究。